Stevanato Group SpA - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
STVN New York 3841 https://www.stevanatogroup.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Stevanato Group SpA

Should You Invest in Stevanato Group S.p.A. (STVN)? - May 25th, 2023 8:01 am
Stevanato Group to Present at Upcoming Investor Conferences - May 24th, 2023 8:01 pm
Stevanato Group S.p.A. (NYSE:STVN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$31.50 - May 6th, 2023 12:09 pm
As Covid Wanes, Maker Of Glass Vials, Other Medical Products Misses Estimates - May 5th, 2023 3:23 pm
Stevanato Group (STVN) Q1 Earnings Lag Estimates - May 4th, 2023 12:05 pm
Stevanato Group Reports First Quarter 2023 Financial Results - May 4th, 2023 10:31 am
Stevanato Group to Present at BofA Securities Healthcare Conference - May 2nd, 2023 10:30 am
Will Akebia Therapeutics (AKBA) Report Negative Q1 Earnings? What You Should Know - May 1st, 2023 2:01 pm
Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy? - Apr 27th, 2023 2:02 pm
Stevanato Group S.p.A. (STVN) Hit a 52 Week High, Can the Run Continue? - Apr 18th, 2023 1:15 pm
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023 - Apr 17th, 2023 8:30 pm
Here's Why You Should Hold Teladoc Health (TDOC) Stock Now - Apr 13th, 2023 4:37 pm
Does Stevanato Group S.p.A. (NYSE:STVN) Create Value For Shareholders? - Mar 31st, 2023 3:03 pm
Stevanato Group S.p.A. (STVN) Hits Fresh High: Is There Still Room to Run? - Mar 30th, 2023 1:15 pm
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market - Mar 21st, 2023 10:30 am
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products - Mar 16th, 2023 12:00 pm
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Mar 14th, 2023 10:00 am
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth - Mar 8th, 2023 5:30 pm
Surging Earnings Estimates Signal Upside for Stevanato (STVN) Stock - Mar 7th, 2023 5:20 pm
Stevanato Group S.p.A. (NYSE:STVN) Q4 2022 Earnings Call Transcript - Mar 6th, 2023 3:00 pm